Egypt Liver Cancer Diagnostics Market, By Test Type (Blood Tests, Imaging Tests, Biopsy, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2028F
South Korea Precision Medicine Market By Products & Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, Next Generation Sequencing (NGS), Others), By Application (Oncology, Cardiology, Respiratory, Neurology, Immunology, Others), By End User (Pharmaceutical and Biotechnology Companies, Healthcare IT, Diagnostic Companies, Clinical Research Organization, Research Institutes), By Region, Competition Forecast & Opportunities, 2018-2028F
Next-Generation IVD Market - A Global and Regional Analysis: Focus on Products, Type, Application, End User, and Regional Analysis - Analysis and Forecast, 2023-2033
Global EV-Based Liquid Biopsy Market Overview
The global EV-based liquid biopsy market was valued at $78.22 million in 2022 and is anticipated to reach $455.53 million by 2032, witnessing a CAGR of 19.73% during the forecast period 2023-2032. The global …
CDx Development Market (2nd Edition): Distribution by Type of Service Offered (Feasibility Studies, Assay Development, Analytical Validation, Clinical Validation and Manufacturing), Analytical Technique Used (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry / in situ Hybridization (IHC / ISH), Liquid Biopsy and Others), Therapeutic Areas (Oncological and Non-oncological) and Key Geographies (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
Global Liquid Biopsy Market Size study & Forecast, by Product and Services (Kits & Reagents, Platforms & Instruments, Services) by Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA [ctDNA], Other Biomarkers), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Other Cancers), by End-user (Hospitals & Laboratories and Government & Academic Research Centers) and Regional Analysis, 2023-2030
Global Next-Generation Breast Cancer Diagnostic and Screening Market: Industry Overview
The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032, …
Global Multicancer Screening Market Industry Overview
The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032. The growth in the glob…
The liquid biopsy in cancer diagnostic market is expected to grow at a strong CAGR of around 15% during the forecast period owing to the surge in the incidence of cancers, rising research and development activities for the development of novel liquid biop…
Global Breast Biopsy Market is valued at approximately USD 691.74 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1 % over the forecast period 2022-2029. Breast biopsies can also be used to test for other disorders tha…